COVID-19 And Lingering Symptoms In Primary Care Patients
CALIP
1 other identifier
observational
300
11 countries
13
Brief Summary
The ongoing corona virus disease 2019 (COVID-19) is a viral acute respiratory tract infection caused by server acute respiratory syndrom coronavirus typ 2 (SARS-CoV-2). The signs and symptom of SARS-CoV-2 infection vary and most people with COVID-19 experience illness of mild or moderate severity and recover with symptomatic treatment outside of hospital. Studies have found that some people experience lingering/long-lasting symptoms and only a minority of patients were completely free from COVID-19 related symptoms after two months. About one third still had up to two residual symptoms and 55% had three or more. As far as we know no study on lingering symptoms has been published in patients after a mild or moderate infection managed in primary care settings. The aim of this study is to explore the course of disease over a one year period and describe lingering symptoms and their impact on well-being and daily activities in adult non-hospitalized patients with previous established COVID-19 infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2020
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 12, 2020
CompletedFirst Submitted
Initial submission to the registry
March 7, 2021
CompletedFirst Posted
Study publicly available on registry
March 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedSeptember 4, 2025
August 1, 2025
1.5 years
March 7, 2021
August 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Time to full recovery symptoms
Number of weeks until "back to normal"
through study completion, a maximum of 1 year
Eligibility Criteria
Adult patients over all age categories with laboratory confirmed SARS-CoV-2 infection and symptoms consistent with COVID-19
You may qualify if:
- Confirmed SARS-CoV-2 infection, either by polymeras chain reaction (PCR), or by antigen testing (if authorized/recommended/used by national/local governments)
- Symptoms consistent with mild to moderate COVID-19
- Maximum of 2 weeks since positive SARS-CoV-2 test
- Aged 18 years and older
- Patient able and willing to comply with monthly phone calls.
You may not qualify if:
- Hospitalisation due to COVID-19
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Katarina Hedinlead
- Research Unit for General Practice in Aalborgcollaborator
- Utrecht Universitycollaborator
- National University of Ireland, Galway, Irelandcollaborator
- Region Jönköping Countycollaborator
Study Sites (13)
Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), Faculty of Medicine and Health Sciences, University of Antwerp
Antwerp, Belgium
the Academic Centre for General Practice (ACHG), Department of Public Health and Primary Care, KU Leuven
Leuven, Belgium
Center for General Practice at Aalborg University
Aalborg, Denmark
Département de Santé Publique, Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, Nice, France
Nice, France
R. Lugar Center for Public Health Research
Tbilisi, Georgia
Institut für Allgemeinmedizin Universitätsklinikum Würzburg Josef-Schneider-Str. 2/D7 97080 Würzburg
Würzburg, Germany
School of Medicine, National University of Ireland
Galway, Ireland
Covid-19 primary care special unit Sassuolo, Azienda Unità Sanitaria locale di Modena, Modena, Italy
Modena, Italy
Julius Center, University Medical Center Utrecht
Utrecht, Netherlands
Medical University of Lodz, Lodz
Lodz, Poland
Balan Medfam SRL
Cluj-Napoca, Romania
Wetterhälsan Primary Health Care Centre
Jönköping, Sweden
Kärna Primary Health Care Centre
Linköping, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Katarina Hedin, Assoc Prof
Region Jönköping County Sweden
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Adjunct professor
Study Record Dates
First Submitted
March 7, 2021
First Posted
March 24, 2021
Study Start
December 12, 2020
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
September 4, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share